Blood levels of matrix metalloproteinases (MMPs) and tissue inhibitors of matrix matalloproteinases (TIMPs) as biomarkers of COPD.

D. Dimov (Stara Zagora, Bulgaria), T. Tacheva (Stara Zagora, Bulgaria), D. Ivanova (Stara Zagora, Bulgaria), Y. Zhelyazkova (Stara Zagora, Bulgaria), D. Vlaykova (Stara Zagora, Bulgaria), M. Gulubova (Stara Zagora, Bulgaria), T. Vlaykova (Stara Zagora, Bulgaria)

Source: International Congress 2018 – Functional genomics and COPD: new challenges
Session: Functional genomics and COPD: new challenges
Session type: Thematic Poster
Number: 942
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Dimov (Stara Zagora, Bulgaria), T. Tacheva (Stara Zagora, Bulgaria), D. Ivanova (Stara Zagora, Bulgaria), Y. Zhelyazkova (Stara Zagora, Bulgaria), D. Vlaykova (Stara Zagora, Bulgaria), M. Gulubova (Stara Zagora, Bulgaria), T. Vlaykova (Stara Zagora, Bulgaria). Blood levels of matrix metalloproteinases (MMPs) and tissue inhibitors of matrix matalloproteinases (TIMPs) as biomarkers of COPD.. 942

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: